Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Titanium alloy patent landscape 2026: aerospace lightweighting and medical implants. Key alloy systems, IPC codes, assignees, and how to build a rigorous IP dataset.
Article | Report Explore the 2026 thermoelectric materials landscape: Bi₂Te₃, PbTe, and Half-Heusler alloys for waste heat recovery. Patent trends, ZT advances, and IP intelligence.
Article | Report Belantamab mafodotin (Blenrep) Phase III DREAMM readouts, reformulated combinations, and the GSK vs. daratumumab BCMA race in multiple myeloma.
Article | Report A 2026 technology landscape of continuous wearable blood pressure monitors: PTT, PPG, edge AI, ISO compliance, and key patent assignees mapped from 2012–2025 filings.
Article | Report How do model-based and measurement-based EMF simulation methods differ for vehicle antenna placement? A technical guide for automotive RF and EMC engineers.
Article | Report Depemokimab (Exdensur), GSK's ultra-long-acting anti-IL-5 biologic, offers twice-yearly dosing for severe asthma and CRSwNP. Explore the competitive IL-5 inhibitor landscape.
Article | Report Explore the core engineering challenges in next-generation flow chemistry platforms for continuous pharmaceutical synthesis, from reactor fouling to regulatory compliance.
Article | Report Patent and literature evidence maps ethanol's role as a marine fuel in 2026: combustion approaches, key assignees, geographic hotspots, and emerging IP white spaces.
Article | Report HIL vs SIL testing for autonomous vehicle validation: understand the key differences, use cases, and how each method fits the V-model development cycle.
Article | Report Sanofi's rilzabrutinib is a reversible BTK inhibitor in Phase III trials for immune thrombocytopenia. Explore late-stage data and the competitive landscape.
Article | Report The zinc-ion battery materials landscape for grid-scale energy storage in 2026: key research directions, patent intelligence gaps, and how to navigate this emerging space.
Article | Report Explore the key engineering tradeoffs between direct and indirect hydrogen storage for mobile fuel cell applications, from compressed gas to LOHC and ammonia cracking.
Article | Report Mapping the 2026 continuous lactate monitor landscape: patent leaders, sensor technologies, clinical applications, and emerging IP white spaces across ICU, sports, and beyond.
Article | Report Amlitelimab's Phase III SOLO program targets drug-free remission in atopic dermatitis — a paradigm shift beyond dupilumab. Explore the OX40L mechanism and competitive landscape.
Article | Report Mapping the 2026 on-orbit satellite servicing patent landscape: engagement systems, debris removal, logistics optimisation, and emerging IP white spaces.